AI governance is not merely a regulatory requirement, but also the strategic infrastructure that enables sustainable ...
Learn how NK cell therapy is a powerful alternative to CAR-T therapies for multiple myeloma, targeting B-cell maturation with ...
Recently, artificial intelligence (AI ) company OpenProtein.AI announced its partnership with large pharmaceutical ...
Rapid scientific transformation is prompting life-science leaders to reevaluate trainings and other measures for increasing ...
Andelyn Biosciences and ENCell collaborate to streamline gene therapy development, leveraging US–APAC networks for faster ...
PhD, is an Associate Director of Marketing at Lonza, where he leads global marketing and go-to-market strategy for advanced ...
EU Biotech Act I simplifies trials, boosts biomanufacturing, and aims for €10B investment to strengthen Europe's health ...
ISPE names 2026 FOYA winners, including AstraZeneca, Takeda, Bayer, and more, recognized for innovation, sustainability, and ...
Acumetis, formed by merging five firms, offers strategic support for life sciences, with 350 experts across 50+ markets and ...
Regeneron and Telix join forces in a 50/50 collaboration to develop and commercialize next-gen radiopharmaceuticals, ...
Explore how modular facilities and single-use technologies enable scalable, compliant biomanufacturing for global commercial ...
Middle East conflict disrupts pharma supply chains, raising costs and risking shortages of key medicines globally.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results